Сила цикла. Как использовать непостоянство гормонов, чтобы жить на полную - [93]
«Тот факт, что слизистая оболочка одного из ваших органов периодически отслаивается, не определяет, кто вы есть на самом деле и как мир видит вас… Месячные вас не определяют». Bliss, C. (2018) Там же.
Adeniji, A. A. et al (2016) Metabolic effects of a commonly used combined hormonal oral contraceptive in women with and without polycystic ovary syndrome, Journal of Women’s Health, 25(6), pp. 638–645.
Akin, M. et al (2004) Continuous, low-level, topical heat wrap therapy as compared to acetaminophen for primary dysmenorrhoea, Journal of Reproductive Medicine, 49(9), pp. 739–745.
Allahbadia, G. and Merchant, R. (2011) Polycystic ovary syndrome and impact on health, Middle East Fertility Society Journal, 16(1), pp. 19–37.
Asvold, B. O., Vatten, L. J. and Bjøro, T. (2013) Changes in the prevalence of hypothyroidism: the HUNT study in Norway, European Journal of Endocrinology, 169(5), pp. 613–620.
BMJ (2004) 328:1199.
Borsos, A. et al (1988) Ibid.
Bouaziz, J. et al (2017) The clinical significance of endocannabinoids in endometriosis pain management, Cannabis and cannabinoid research, 2(1), pp. 72–80.
Canaris, G. J. et al (2000) The Colorado thyroid disease prevalence study, Archives of Internal Medicine, 160(4), pp. 526–534.
Ciavattini, A. et al (2017) Ovarian endometriosis and vitamin D serum levels, Gynaecology Endocrinology, 33(2), pp. 164–167.
Dehnavi, Z. M., Jafarnejad, F. and Kamali, Z. (2018) The effect of aerobic exercise on primary dysmenorrhoea: a clinical trial study, Journal of Education and Health Promotion, 7(3).
Ding, T. et al (2017) The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis, Oncotarget, 8(56), pp. 96351–96358.
Dubet, N. et al (2016) The ESC/E(Z) complex, an intrinsic cellular molecular pathway differentially responsive to ovarian steroids in premenstrual dysphoric disorder, Molecular Psychiatry, 22(18), pp. 1172–1184.
Edlund, M. et al (1996) On the value of menorrhagia as a predictor for coagulation disorders, American Journal of Hematology, 53 (4), pp. 234–238. Kadir, R. A. et al (1998) Frequency of inherited bleeding disorders in women with menorrhagia, Lancet, 351(9101), pp. 485–489.
Falsetti, L. et al (2002) Long-term follow-up of functional hypothalamic amenorrhea and prognostic factors, Journal of Clinical Endocrinology Metabolism, 87(2), pp. 500–505.
Falsetti, L. et al (2002) Long-term follow-up of functional hypothalamic amenorrhea and prognostic factors, Journal of Clinical Endocrinology Metabolism, 87(2), pp. 500–505.
Grandi, G. et al (2012) Prevalence of menstrual pain in young women: what is dysmenorrhoea? Journal of Pain Research, 5, pp. 169–174.
Halme, J. et al (1984) Retrograde menstruation in healthy women and in patients with endometriosis, Obstetrics and Gynaecology, 64(2), pp. 151–154.
Hoffmann, D. E. and Tarzian, A. J. (2001) The girl who cried pain: A bias against women in the treatment of pain, The Journal of Law, Medicine and Ethics, 29(1), pp. 13–27.
Hubacher, D., Chen, P. L. and Park, S. (2009) Side effects from the copper IUD: do they decrease over time? Contraception, 79(5), pp. 356–362.
Huo, L. et al (2007) Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene, Biological Psychiatry, 62(8), pp. 925–933.
Jacobstein, R. and Polis, C. B. (2014) Progestin-only contraception: injectables and implants, Best Practice and Research. Clinical Obstetrics and Gynaecology, 28(6), pp. 795–806.
Keshavarzi, F. et al (2018) Both melatonin and meloxicam improved sleep and pain in females with primary dysmenorrhoea — results from a double-blind crossover intervention pilot study, Archives of Women’s Mental Health, 21(6), pp. 601–609.
Kessler, L. et al (2010) Changes in serum TSH and free T4 during human sleep restriction, Sleep, 33(8), pp. 1115–1118.
Kohn, J. R. et al (2017) Pregnancy after endometrial ablation: a systematic review, BJOG, 125(1), pp. 43–53. ‘Supplementing with iron can help to recover from heavy blood loss and prevent further excessive loss’: Taymor, M. L., Sturgis, S. H. and Yahia, C. (1964) The etiological role of chronic iron deficiency in production of menorrhagia, JAMA, 187, pp. 323–327.
Lethaby, A., Augood, C. and Duckitt, K. (2000) Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding, The Cochrane Database of Systematic Reviews, 2.
Marziali, M. et al (2012) Gluten-free diet: a new strategy for management of painful endometriosis related symptoms? Minerva Chirurgica, 67(6), pp. 499–504.
Mesen, T. B. and Young, S. L. (2015) Progesterone and the luteal phase, a requisite to reproduction, Obstetrics and Gynecology Clinics of North America, 42(1), pp. 135–151.
Metcalf, M. G. et al (1983) Ibid.
Mortavazi, S. et al (2009) Alterations in TSH and thyroid hormones following mobile phone use, Oman Medical Journal, 24(4), pp. 274–278.
